The overall aim of this research is to identify the potential co-occurrence of genomic variants beyond mutations in the SACS gene and the epigenetic effects that might explain the different phenotype severity existing among ARSACS patients.
Duration : one year
Dr. Daniele Galatolo
Molecular Medicine for Neurodegenerative and Neuromuscular Diseases Unit
IRCCS Stella Maris Foundation
via dei Giacinti 2,
56128 Calambrone (Pisa) – Italy
email : firstname.lastname@example.org